Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,188.5
-9.6 (-0.30%)

 

  • STI Straits Times Index
    3,188.5
    -9.6 (-0.30%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,591.6
    -14.7 (-0.92%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,017.5
    -118.5 (-0.45%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,594.8
    7.8 (0.22%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,708.6
    -547.0 (-1.87%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,633.0
    -23.0 (-0.35%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,695.9M
  • Value: 946.0M
  • Rise: 169
  • Fall: 162
  • Unch: 420

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
King Wan0.057+0.006
Metal Component0.058+0.006
Hatten Land0.071-0.001
Sinjia Land0.079+0.001
Tritech0.022-0.004
Shen Yao0.003-
Jiutian Chemical0.087-
Rex Intl0.350+0.005
BlackGoldNatural0.021+0.002
Ntegrator Intl0.009-

World Indices

World Indices
Name Last Change
Nasdaq 15,121.7 -7.4
HSI 26,017.5 -118.5
HSCEI 9,273.6 -3.1
Jakarta 6,633.0 -23.0
Nikkei 225 28,708.6 -547.0
SSE Comp 3,594.8 +7.8
Shanghai A 3,767.5 +8.1
Shanghai B 277.5 +1.1
KOSPI 3,007.3 -5.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CLARITY PHARMACEUTICALS LTD CLARITY PHARMACEUTICALS
Updated on 21 Oct 2021 (End of trading day)
Last (AUD): 1.100 Change: - High: 1.130 Remarks: -
Change (%): - Low: 1.100
Open 1.110 Yesterday's Close 1.1
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 133,408 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.03991 Trailing EPS (AUD) e -0.03991 NAV (AUD) b 0.0792
PE a - Trailing PE f - Price / NAV b 13.8889
Dividend (AUD) d - Cash In Hand (AUD) g 0.0329 Issued & Paid-up Shares c 256,133,000
Dividend Yield (%) d - Price / Cash In Hand g 33.435 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 281.746
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 262.807
Piotroski F Score 3 Exchange Code CU6 Par Value ( AUD ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 79.7
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 25 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 27 Jul 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CLARITY PHARMACEUTICALS LTD ASX 281.746 - - 13.8889 -
Industry Medical Specialties ASX 2,205.651 66.423 65.845 9.6648 0.848
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 16,701.350 34.120 34.120 11.9426 1.440
Local Peer COCHLEAR LTD ASX 14,467.891 44.312 44.312 8.5020 1.159
Local Peer EBOS GROUP ASX 5,664.314 30.569 30.569 4.0143 2.492
Local Peer NANOSONICS LIMITED ASX 1,770.515 206.399 206.402 13.0590 -
Local Peer METRICS INCOME OPPORTUNITIES TRUST ASX 600.218 - - -420.4082 -
Local Peer INCANNEX HEALTHCARE LTD ASX 422.986 - - 49.2958 -
Local Peer AROA BIOSURGERY LTD ASX 386.305 - - 7.1837 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 355.727 - - 5.2082 -
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 314.191 - - - -
Local Peer IMPEDIMED LIMITED ASX 254.507 - - 10.0000 -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 213.443 - - 21.2364 -
Local Peer ATOMO DIAGNOSTICS LIMITED ASX 193.323 - - 6.4272 -
Other Local Peers SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), MICRO-X LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), OPTISCAN IMAGING (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), CLEANSPACE HOLDINGS LTD (ASX), SDI LTD (ASX), DIMERIX LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), COMPUMEDICS (ASX), CARDIEX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), RESONANCE HEALTH LTD (ASX), RESPIRI LTD (ASX), LBT INNOVATIONS LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), ADHERIUM LIMITED (ASX), OVENTUS MEDICAL LTD (ASX), TRUSCREEN GROUP LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), USCOM LTD (ASX), METALICITY LIMITED (ASX), ANALYTICA (ASX)
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 238,254.546 37.373 27.717 6.4648 0.147
Global Peer DANAHER CORP NYSE 224,749.998 64.031 64.031 5.6916 0.228
Global Peer ABBOTT LABORATORIES NYSE 218,606.434 48.872 34.448 6.4676 1.240
Global Peer MEDTRONIC PLC NYSE 163,906.200 45.454 42.211 3.1835 1.986
Global Peer INTUITIVE SURGICAL INC NASDAQ 121,299.086 114.368 74.756 - -
Global Peer STRYKER CORP NYSE 103,233.801 64.561 49.560 7.4699 0.858
Global Peer EDWARDS LIFESCIENCES CORP NYSE 72,056.717 87.511 49.273 14.0371 -
Global Peer BECTON DICKINSON & CO NYSE 70,907.211 92.447 38.020 2.9382 1.309
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,318.609 - 135.296 3.9718 -
Global Peer IDEXX LABORATORIES INC NASDAQ 54,635.743 93.912 75.065 73.0952 -
Other Global Peers DEXCOM INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), PERKINELMER INC (NYSE), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), ABIOMED INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), NOVOCURE LTD (NASDAQ), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), MICROPORT SCIENTIFIC CORPORATION (HKEx), TANDEM DIABETES CARE INC (NASDAQ), SHANDONG WEIGAO GROUP MEDICAL (HKEx), GLOBUS MED INC (NYSE), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), ANGELALIGN TECHNOLOGY INC (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), STEVANATO GROUP S.P.A. (NYSE), INMODE LTD (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), STAAR SURGICAL CO (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), QUIDEL CORP (NASDAQ), Top Glove (SGX), TOPGLOV (Bursa), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), INARI MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), NEVRO CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), CAREDX INC (NASDAQ), HAEMONETICS CORP (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), VENUS MEDTECH (HANGZHOU) INC (HKEx), LIFETECH SCIENTIFIC CORP (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), GLAUKOS CORPORATION (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), BIOLIFE SOLUTIONS INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), PEIJIA MEDICAL LIMITED (HKEx), MESA LABORATORIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), CUE HEALTH INC (NASDAQ), KANGJI MEDICAL HLDGS LTD (HKEx), INOVIO PHARMACEUTICALS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), PARAGON 28 INC (NYSE), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), TREACE MED CONCEPTS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), SUPERMX (Bursa), ATRION CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), VICARIOUS SURGICAL INC (NYSE), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), INOGEN INC (NASDAQ), 908 DEVICES INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), DERMTECH INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), BIOVENTUS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), SISRAM MEDICAL LTD (HKEx), SURMODICS INC (NASDAQ), CUTERA INC (NASDAQ), SI BONE INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), INTERCURE LTD (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), NYXOAH SA (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), VAPOTHERM INC (NYSE), PAVMED INC (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), STEREOTAXIS INC (NYSE American), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), ACCELERATE DIAGNOSTICS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEUROPACE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), SIENTRA INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CVRX INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), TALIS BIOMEDICAL CORP (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), ONCOCYTE CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), EARGO INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), QUOTIENT LTD (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), CYTOSORBENTS CORP (NASDAQ), CONFORMIS INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), TELA BIO INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), INTRICOM CORP (NASDAQ), INVACARE CORP (NYSE), ENLIVEX THERAPEUTICS LTD (NASDAQ), Medtecs Intl (SGX), UGHealthcare (SGX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), NEURONETICS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KELFRED HOLDINGS LTD (HKEx), IRIDEX CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), FONAR CORP (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), ALPHA PRO TECH (NYSE American), MEDAVAIL HOLDINGS INC (NASDAQ), ENVVENO MED CORP (NASDAQ), CHECK-CAP LTD (NASDAQ), BIOLASE INC (NASDAQ), ELECTROMED INC (NYSE American), RGTBHD (Bursa), LENSAR INC (NASDAQ), CELSION CORPORATION (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), AVINGER INC (NASDAQ), IMMUCELL CORP (NASDAQ), ELECTROCORE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), BIOMERICA INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), APPLIED UV INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), NEOVASC INC (NASDAQ), NEUROMETRIX INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), NUTRIBAND INC (NASDAQ), DAXOR CORP (NYSE American), YUNNAN ENERGY INTL CO LTD (HKEx), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), Biolidics (SGX), ADVENTA (Bursa), BELLEROPHON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), Yunnan Energy (SGX), INSPIREMD INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), LKL (Bursa), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), XTANT MEDICAL HLDGS INC (NYSE American), THERMOGENESIS HOLDINGS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), NUWELLIS INC (NASDAQ), CYANOTECH CORP (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), Annica (SGX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.020
-1.79 %
10 Days --0.055
-4.76 %
20 Days --0.150
-12.00 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.057 - 1.710 Change From 1 Year Low +0.043 % Change From 1 Year Low (%) +4.07
Change From 1 Year High -0.610 % Change From 1 Year High (%) -35.67
2 Years Range 1.057 - 1.710 Change From 2 Years Low +0.043 % Change From 2 Years Low (%) +4.07
Change From 2 Years High -0.610 % Change From 2 Years High (%) -35.67
5 Years Range 1.057 - 1.710 Change From 5 Years Low +0.043 % Change From 5 Years Low (%) +4.07
Change From 5 Years High -0.610 % Change From 5 Years High (%) -35.67
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Clarity Pharmaceuticals Ltd. engages in the development of radiopharmaceutical products focused on the treatment of serious diseases. It offers SAR Technology platform that enables targeted theranostic radiopharmaceuticals for both the diagnosis and treatment. The company was founded by Matthew Harris in 2010 and is headquartered in Eveleigh, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Oct 2021 1.110 1.130 1.100 1.100 133,408 -
20 Oct 2021 1.120 1.120 1.095 1.100 168,962 -
19 Oct 2021 1.100 1.140 1.100 1.130 111,612 -
18 Oct 2021 1.105 1.125 1.075 1.100 372,646 -
15 Oct 2021 1.120 1.145 1.080 1.100 506,839 -
14 Oct 2021 1.075 1.145 1.075 1.120 443,993 -
13 Oct 2021 1.080 1.150 1.070 1.075 41,910 -
12 Oct 2021 1.070 1.105 1.070 1.070 243,253 -
11 Oct 2021 1.180 1.180 1.057 1.080 352,754 -
08 Oct 2021 1.170 1.180 1.105 1.135 200,962 -
07 Oct 2021 1.155 1.195 1.140 1.155 2,877,133 -
06 Oct 2021 1.190 1.190 1.100 1.135 174,053 -
05 Oct 2021 1.260 1.260 1.165 1.170 80,766 -
04 Oct 2021 1.275 1.275 1.200 1.260 140,481 -
01 Oct 2021 1.335 1.335 1.250 1.250 940,545 -
30 Sep 2021 1.230 1.340 1.230 1.340 256,359 -
29 Sep 2021 1.220 1.240 1.100 1.240 375,087 -
28 Sep 2021 1.220 1.260 1.200 1.220 62,449 -
27 Sep 2021 1.280 1.280 1.210 1.220 139,673 -
24 Sep 2021 1.265 1.270 1.235 1.260 106,783 -
23 Sep 2021 1.290 1.290 1.220 1.250 204,533 -
22 Sep 2021 1.300 1.300 1.240 1.270 198,832 -
Summary
Current 2 Weeks
(08 Oct 2021 to 21 Oct 2021)
1.170 1.180 1.057 1.100 2,576,339 -
Previous 2 Weeks
(24 Sep 2021 to 07 Oct 2021)
1.265 1.270 1.057 1.155 5,153,329 -
4 Weeks from
(27 Aug 2021 to 23 Sep 2021)
1.405 1.475 1.057 1.250 7,601,136 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.